Bollikonda Satyanarayana
Research Subjects
Bollikonda Satyanarayana has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Padi Pratap Reddy
Research and Development, Macleods Pharmaceuticals Ltd., Andheri(E), Mumbai 400093, India
2 shared publications Alok Kumar Srivastava
Dr. Reddy's Laboratories Ltd., IPDO-IPM Communication No. 00056, Hyderabad, India
1 shared publicationB.V.V.N. Chandra Sekhar
Dr. Reddy's Laboratories Ltd., IPDO-IPM Communication No. 00056, Hyderabad, India
1 shared publicationBolugoddu Vijayabhaskar
Research and Development, Dr. Reddy‘s Laboratories Ltd., Hyderabad 500072, India
1 shared publicationChandrashekar R. Elati
Research and Development, Dr. Reddy‘s Laboratories Ltd., Hyderabad 500072, India
1 shared publicationJ. Moses Babu
Dr. Reddy's Laboratories Ltd., IPDO-IPM Communication No. 00056, Hyderabad, India
1 shared publication
Latest Publications
- Open Access
- 19 December 2011
- Published by Wiley in Journal of the Chinese Chemical Society
- Vol. 58 (7) , 841-845
A Novel and Efficient Synthesis of Dronedarone Hydrochloride, an Antiarrhythmic Drug Substance
- 19 December 2011
- Published by Wiley in Journal of the Chinese Chemical Society
- Vol. 58 (7) , 841-845
Open AccessA Novel and Efficient Synthesis of Dronedarone Hydrochloride, an Antiarrhythmic Drug Substance
- 4 November 2008
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (3) , 708-715
Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium
- 4 November 2008
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (3) , 708-715
Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium
- 6 March 2007
- Published by Taylor & Francis in Synthetic Communications
- Vol. 37 (4) , 545-549
New and Improved Synthesis of Montelukast, an Anti‐asthmatic Drug
A new industrially viable synthesis of Montelukast, an anti‐asthmatic drug, is described.
- 6 March 2007
- Published by Taylor & Francis in Synthetic Communications
- Vol. 37 (4) , 545-549
New and Improved Synthesis of Montelukast, an Anti‐asthmatic Drug
A new industrially viable synthesis of Montelukast, an anti‐asthmatic drug, is described.